CSB 2.012 Note (rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);

CSB 2.012 Note (18) Paragraph (tg) of s. 161.14 (2), Stats., is created to read:

CSB 2.012 Note (tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);

CSB 2.012 Note (19) Paragraph (xm) of s. 161.14 (2), Stats., is created to read:

CSB 2.012 Note (xm) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);

CSB 2.012 History History: Cr. Register, February, 1988, No. 386, eff. 3-1-88.

CSB 2.012 Note CSB 2.20 Addition of beta-hydroxy-3-methylfentanyl to schedule I. Paragraph (er) of s. 161.14 (2), Stats., is created to read:

CSB 2.012 Note (er) Beta-hydroxy-3-methylfentanyl.

CSB 2.012 History History: Cr. Register, July, 1989, No. 403, eff. 8-1-89.

CSB 2.012 Note CSB 2.21 Additions, deletions, corrections, transfers, and amendments to drug schedules. (1) Subsection (1) of s. 161.14, Stats., is amended to read:

CSB 2.012 Note (1) Included substances. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I.

CSB 2.012 Note (2) Paragraph (a) of s. 161.14 (2), Stats., is amended to read:

CSB 2.012 Note (a) Acetyl-alpha-methylfentany (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylacetamide);

CSB 2.012 Note (3) Paragraph (er) of s. 161.14 (2), Stats., is amended to read:

CSB 2.012 Note (er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2- phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);

CSB 2.012 Note (4) Paragraph (rg) of s. 161.14 (2), Stats., is amended to read:

CSB 2.012 Note (rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);

CSB 2.012 Note (5) Paragraph (qs) of s. 161.14 (2), Stats., is amended to read:

CSB 2.012 Note (qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
piperidinyl]-N-phenylpropanamide);

CSB 2.012 Note (6) Paragraph (tg) of s. 161.14 (2), Stats., is amended to read:

CSB 2.012 Note (tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);

CSB 2.012 Note (7) Paragraph (vg) of s. 161.14 (2), Stats., is amended to read:

CSB 2.012 Note (vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);

CSB 2.012 Note (8) Paragraph (xm) of s. 161.14 (2), Stats., is amended to read:

CSB 2.012 Note (xm) Thiofentanyl (N-[1-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide);

CSB 2.012 Note (9) Paragraph (cd) of s. 161.14 (2), Stats., is created to read:

CSB 2.012 Note (cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);

CSB 2.012 Note (10) Paragraph (e) of s. 161.14 (3), Stats., is amended to read:

CSB 2.012 Note (e) Codeine-N-oxide;